Advanced Search
LI Jin, TENG Lisong, WANG Weibin. Relationship between Preoperative Serum TSH Levels and Expression of VEGF in Differentiated Thyroid Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 455-458. DOI: 10.3971/j.issn.1000-8578.2013.05.011
Citation: LI Jin, TENG Lisong, WANG Weibin. Relationship between Preoperative Serum TSH Levels and Expression of VEGF in Differentiated Thyroid Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 455-458. DOI: 10.3971/j.issn.1000-8578.2013.05.011
shu

Relationship between Preoperative Serum TSH Levels and Expression of VEGF in Differentiated Thyroid Carcinoma

  • 1.Department of Surgical Oncology，First Affiliated Hospital of Zhejiang University,Hangzhou 310003,China；2.Department of Surgical Oncology，First Hospital of Jiaxing

More Information
  • Received Date: May 24, 2012
  • Revised Date: January 14, 2013
    Graphical Abstract
    • Abstract
  • Objective To elucidate whether immunohistochemical expression of VEGF is related to serum TSH level. Methods The VEGF expression was analyzed in 43 archived differentiated thyroid carcinoma specimens using immunohistochemistry.The adjacent normal thyroid tissues were used as controls.TSH in serum samples from 43 patients was measured by immunoradiometric assay before surgery.A statistical correlation was observed between serum TSH levels and VEGF expression in DTC tissues. Results The incidences of positive expression were 90.7% for VEGF in 43 DTC tissues,while 0% in normal tissues.The serum TSH levels revealed a significant positive correlation with VEGF expression （r=0.592，P＜0.01）. Conclusion The serum TSH levels reveal a significant positive correlation with VEGF expression,and they may predict the initiation,progression and prognosis of differentiated thyroid carcinoma.
    • FullText(HTML)
    • References (13)
  • [1]
    American Cancer Society.Cancer facts and figures 2008[R].Atlanta：American Cancer Society,2008.
    [2]
    Mitchell I，Livingston EH,Chang AY,et al．Trends in thyroid cancer demographics and surgical therapy in the United States[J].Surgery,2007,42(6)：823-8．
    [3]
    Ji B,Wang GY,Zhang P,et al.Relationship between COX-2 and VEGF expression in thyroid cancer  and angiogenesis and clinical pathology [J].Jilin Da Xue Xue Bao(Yi Xue Ban),2006,32(6)：1077-80.[纪柏， 王广义，张平，等．甲状腺癌COX-2和VEGF的表达与血管生成及临床病理的关系[J]．吉林大学学报(医学版)，2006 ，32(6)：1077- 80.]
    [4]
    Fenton C,Patel A,Dinauer C,et al.The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults[J]，Thyroid，2000,10(4):349-57.
    [5]
    Klein M,Vignaud JM,Hennequin V,et al.Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma [J].J Clin Endocrinol Metab,2001,86(2):656-8.
    [6]
    Lennard CM,Patel A,Wilson J,et al.Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer[J].Surgery,2001,129(5):552-8.
    [7]
    Boelaert K,Horacek J,Holder RL,et al.Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine- needle aspiration[J].J Clin Endocrinol Metab,2006,91(11):4295-301.
    [8]
    Haymart MR,Repplinger DJ,Leverson GE,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-14.
    [9]
    Shi LF,Guan HX,Li YS,et al.The relationship between Preoperative serum thyroid-stimulating hormone level and thyroid nodule [J].Zhonghua Nei Fen Mi Dai Xie Za Zhi,2010,26(3):213-4.[史良凤,关 海霞,李玉姝,等.术前血清促甲状腺素水平与甲状腺结节良恶性关系的研究[J].中华内分泌代谢杂志,2010,26 (3):213-4.]
    [10]
    Ma Junfeng,Tang Bo,Li Tiehan,et al.Value of thyroid stimulating hormone inhibition therapy in differentiated thyroid carcinoma[J].Zhongguo Pu Wai Ji Chu Yu Lin Chuang Za Zhi,2009,16(5):348-55.[ 马峻峰，唐波，李铁汉，等．促甲状腺激素抑制疗法在分化型甲状腺癌治疗中的作用[J].中国普外基础与临床杂志 ，2009，16(5)：348-55]．
    [11]
    Li JZ,Liu X,Zhang LY,et al.Relationship between preoperative serum TSH concentrations and differentiated thyroid cancer [J].Shandong Da Xue Xue Bao (Yi Xue Ban),2011,49 (1)：10 -3 [李建周， 刘欣，张凌云，等.术前血清TSH浓度与分化型甲状腺癌的相关性研究[J].山东大学学报(医学版),2011,49(1):10- 3].
    [12]
    Hoelting T，Goretzki PE，Duh QY．Follicular thyroid cancer cells：a model of metastatic tumor in vitro(review)[J].Oncol Rep,2001,8(1):3-8.
    [13]
    Hoffmann S,Hofbauer LC，Scharrenbach V，et al.Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors[J].J Clin Endocrinol Metab,2004,89(12):6139-45.
    • Related Articles

  • Related Articles

    [1]XU Yao, LIU Shiguo, ZHANG Chang, ZHANG Li, JIANG Shan, ZHANG Junxia, PENG Li. Clinical Significance of Detection of ZIC1 Promoter Methylation in Peripheral Blood and Cancer Tissues of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 354-357. DOI: 10.3971/j.issn.1000-8578.2021.20.0911
    [2]WAN Lihui, ZHANG Na, HUANG Ying, LI Wei, WANG Liuhua, ZHENG Yuqin, SUN Zhenzhu, CAO Yuwen. Clinical Significance of JAG1 Gene Methylation in Uygur Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(11): 734-739. DOI: 10.3971/j.issn.1000-8578.2017.17.0501
    [3]KANG Yani, LAI Dengpan, ZHANG Xiaoli, CHEN Jian, ZHAO Xiaodong. CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 871-875. DOI: 10.3971/j.issn.1000-8578.2014.08.003
    [4]SONG Chao, ZHANG Yun, JIN Yongtang, YU Zaicheng, XUE Shaoli. Detection and Clinical Significance of DAPK Gene Methylation in Plasma of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2013, 40(08): 772-775. DOI: 10.3971/j.issn.1000-8578.2013.08.011
    [5]GUO Wei, GUO Yan-li, YANG Zhi-bin, KUANG Gang, QIAO Yi-ling, DONG Zhi-ming. Promoter Methylation of Transforming Growth Factor-beta Receptor Type 1 Gene and Expression of TGF-β1 in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 524-527. DOI: 10.3971/j.issn.1000-8578.2011.05.011
    [6]TAN Shuang-xiang, HU Rui-cheng, XIAO Zhi-qiang, TANG Can-e, YI Hong, RUAN Lin, WANG Ning, HONG Xiu-qin. Methylation of annexin A1 Gene Promotes Lymphoid Node Metastasis in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1374-1379. DOI: 10.3971/j.issn.1000-8578.2010.12.011
    [7]GUO Yan-li, JIN Guo-liang, GUO Wei, KUANG Gang, YANG Zhi-bin, DONG Zhi-ming. Relationship between Promoter Methylation of Wif-1 and Protein Expression of VEGF-C/VEGF-D in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(09): 1044-1047. DOI: 10.3971/j.issn.1000-8578.2010.09.018
    [8]DONG Zhi-ming, GUO Wei, HE Ming, YANG Zhi-bin, KUANG Gang, WANG Shi-jie. Expression and Methylation Status of RASSF1A Gene in Gastric Cardiac Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 566-570. DOI: 10.3971/j.issn.1000-8578.2009.07.008
    [9]YU Zong-tao, YUAN Ya-li, ZHANG Ji-cai, GAO Qiong, WANG Yuan-yuan. Transcriptional Expression and Promoter methylation of FHIT gene in Lung Carcinoma Tissues and Cell[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 498-500. DOI: 10.3971/j.issn.1000-8578.2226
    [10]LIU Fen, YU Jie-ping, DENG Quan-jun, QI Yuan-ling, YU Hong-gang. Studying the Expression of PTEN and Its CpG Island Methylation Status in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 632-634. DOI: 10.3971/j.issn.1000-8578.1326

Catalog

    Get Citation
    PDF
    XML
    Article views (1917) PDF downloads (109) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：11641852 Visits today：9201

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return